← Back to Analyst Consensus 
PDSB Buy
PDS Biotechnology Corp
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 25, 2025 | B. Riley Securities | maintain | Buy → Buy | $3 | 54% |
| Nov 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Jul 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Jun 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Mar 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Mar 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Mar 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Feb 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Nov 25, 2024 | B. Riley Securities | maintain | Buy → Buy | $7 | 54% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Oct 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Sep 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Aug 20, 2024 | Alliance Global Partners | maintain | Buy → Buy | $7 | 41% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jun 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jun 12, 2024 | B. Riley Securities | maintain | Buy → Buy | $9 | 54% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| May 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Mar 28, 2024 | B. Riley Securities | reiterate | Buy → Buy | $11 | 54% |
| Mar 27, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $21 | 44% |
| Nov 15, 2023 | Oppenheimer | maintain | Outperform → Outperform | $20 | 52% |
| Oct 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Sep 27, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Sep 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Aug 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jun 6, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| May 26, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $24 | 52% |
| May 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| May 16, 2023 | Oppenheimer | reiterate | — → Outperform | $24 | 52% |
| Apr 24, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $21 | 44% |
| Mar 30, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $21 | 44% |
| Mar 29, 2023 | B. Riley Securities | reiterate | — → Buy | $12 | 54% |
| Mar 28, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $21 | 44% |
| Feb 28, 2023 | HC Wainwright & Co. | maintain | — → Buy | $21 | 44% |
| Jan 3, 2023 | HC Wainwright & Co. | maintain | — → Buy | $21 | 44% |
| Nov 15, 2022 | Chardan Capital | maintain | — → Buy | $16 | 47% |
| Nov 1, 2022 | B. Riley Securities | initiate | — → Buy | $10 | 54% |
| Aug 12, 2021 | HC Wainwright & Co. | maintain | — → Buy | $15 | 44% |
| Jun 28, 2021 | Cantor Fitzgerald | initiate | — → Overweight | $25 | 50% |
| Jun 9, 2021 | Chardan Capital | maintain | — → Buy | $15 | 47% |
| Jun 2, 2021 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| May 20, 2021 | Chardan Capital | maintain | — → Buy | $11 | 47% |
| Mar 19, 2021 | HC Wainwright & Co. | maintain | — → Buy | $8 | 44% |
Price Target Trend
Jun 5, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days